A non-invasive approach for risk evaluation of Type 2 Diabetes and Hypertension for patients who are at-risk
- Conditions
- Health Condition 1: E115- Type 2 diabetes mellitus with circulatory complications
- Registration Number
- CTRI/2020/11/028880
- Lead Sponsor
- Aarca Research India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Age greater than 30 years with one or more of the following risk factors:
BMI > 25 kg/m²
Elevated waist circumference, > 35 inches for women and > 40 inches for men
Habitually physically inactive (does not exercise regularly)
Has delivered a baby weighing > 4kg or diagnosed with gestational diabetes
Hypertension (>=130/>= 85 mmHg) or being treated for hypertension
HDL cholesterol level < 35 mg/dL and/or a fasting triglyceride level >= 250 mg/dL or being treated for dyslipidemia with medication
Has insulin resistance which can be identified using HOMMA-IR modelling
Has been previously diagnosed with Polycystic Ovary Syndrome (PCOS)
Had impaired glucose tolerance or impaired fasting glucose on previous testing within the last three years
Under 25 years of age
Receiving investigational treatments in the past 14 days
Psychosocial issues that interfere with an ability to follow study procedures
Current chemotherapy, or chemotherapy within the past 12 months
Receiving medications that fluoresce
Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to ultraviolet light, or taking medication known to cause photosensitivity)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the trial will be a model based evaluation system to identify at risk type 2 diabetes patientsTimepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method The secondary outcome will be identifying patients who are at risk for vascular complications like hypertensionTimepoint: 8 weeks